Montelukast Sodium
Product Images NDC 53002-4730

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 53002-4730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530024730)

Label Image (Lbl530024730)
Montelukast Sodium 5mg Chewable Tablets carton label by RPK Pharmaceuticals, Inc. The label indicates a supply of 30 chewable tablets, with directions to chew and swallow one tablet daily or as directed. The packaging includes prescription and dispensing information, lot number, expiration date, and barcode.*
FDA Label Image

Montelukast-fig1.jpg (Montelukast Fig1)

Montelukast-fig1.jpg (Montelukast Fig1)
A line graph titled 'Change in Height (cm) from Randomization Visit by Scheduled Week' shows change in height over 56 weeks of treatment. It compares three groups: Montelukast 5 mg, Beclomethasone 336 mcg, and Placebo. The y-axis represents change in height (cm) ranging from -3 to 7, and the x-axis shows weeks on treatment from -19 to 56. Lines for Montelukast and Beclomethasone show increases in height over time, while Placebo remains relatively flat.*
FDA Label Image

Montelukast-fig2.jpg (Montelukast Fig2)

Montelukast-fig2.jpg (Montelukast Fig2)
A line graph depicting mean percent change from baseline in FEV1 over weeks in treatment for Montelukast Sodium and placebo groups in a U.S. clinical trial. The x-axis shows weeks in treatment up to 15 weeks, including a washout period. The y-axis shows mean percent change from baseline, ranging from 0 to 15 percent. Montelukast Sodium shows a steady increase in FEV1 improvement compared to placebo.*
FDA Label Image

Chemical Structure (Montelukast Str)

Chemical Structure (Montelukast Str)
Chemical structure diagram of Montelukast Sodium showing its molecular arrangement with characteristic functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.